[Variegate porphyria]. 1995

J Arata
Department of Dermatology Okayama University Medical School.

Variegate porphyria was reviewed in the epidemiological, clinical and biochemical aspects. Dual porphyrias were also referred to.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017094 Porphyrias, Hepatic A group of metabolic diseases due to deficiency of one of a number of LIVER enzymes in the biosynthetic pathway of HEME. They are characterized by the accumulation and increased excretion of PORPHYRINS or its precursors. Clinical features include neurological symptoms (PORPHYRIA, ACUTE INTERMITTENT), cutaneous lesions due to photosensitivity (PORPHYRIA CUTANEA TARDA), or both (HEREDITARY COPROPORPHYRIA). Hepatic porphyrias can be hereditary or acquired as a result of toxicity to the hepatic tissues. Hepatic Porphyria,Porphyria, Hepatic,Hepatic Porphyrias

Related Publications

J Arata
May 1979, Harefuah,
J Arata
January 1998, Seminars in liver disease,
J Arata
May 2004, The Journal of dermatology,
J Arata
August 1978, Annals of internal medicine,
J Arata
July 1967, Archives of dermatology,
J Arata
January 1998, Ryoikibetsu shokogun shirizu,
J Arata
June 1996, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
J Arata
April 1984, Lancet (London, England),
J Arata
July 1975, Archives of dermatology,
J Arata
July 1983, Archives of dermatology,
Copied contents to your clipboard!